Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

FLJ37512 Activators

Activators of FLJ37512 function through various biochemical mechanisms to enhance its activity within cellular signaling networks. Certain small molecule activators exert their effects by modulating the levels of intracellular second messengers such as cAMP. By either directly stimulating the production of cAMP or inhibiting its degradation, these molecules can amplify the signaling cascades that converge on FLJ37512, promoting its phosphorylation and consequent activation. Other activators operate through manipulation of protein kinase activity, with some enhancing kinase function to foster phosphorylation events that prime FLJ37512 for activity, while others inhibit specific kinases, creating a compensatory response that can upregulate FLJ37512 activity. The intricate balance of kinase and phosphatase activities plays a pivotal role in the regulation of FLJ37512, as exemplified by compounds that inhibit phosphatase function, leading to a net increase in the phosphorylated and active form of the protein.

Additionally, the regulation of intracellular ion concentrations, particularly calcium, is a critical factor in the activation of FLJ37512. Activators that function as ionophores facilitate the influx of calcium ions, triggering a series of calcium-dependent signaling pathways that can culminate in the activation of FLJ37512. This mechanism underscores the importance of ion gradients in controlling the activity of signaling proteins, where altering the balance of ions can initiate a domino effect through various pathways to modulate the activity of FLJ37512. Other activators interact with G-protein coupled receptors, setting off a chain reaction that not only involves second messengers but also engages multiple kinases and phosphatases, intricately weaving a network of signals that eventually lead to enhanced FLJ37512 function.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

Phosphodiesterase inhibitor, elevates cAMP by preventing its degradation, thereby potentially enhancing FLJ37512 signaling.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PKC activator that may lead to downstream phosphorylation events, influencing the activity of FLJ37512 through phosphorylation-dependent modulation.

H-89 dihydrochloride

130964-39-5sc-3537
sc-3537A
1 mg
10 mg
$94.00
$186.00
71
(2)

Inhibits protein kinase A (PKA), potentially increasing the activity of FLJ37512 through compensatory mechanisms within cAMP signaling.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Calcium ionophore that increases intracellular calcium levels, which could activate calcium-dependent kinases that modulate FLJ37512.

Sodium Fluoride

7681-49-4sc-24988A
sc-24988
sc-24988B
5 g
100 g
500 g
$40.00
$46.00
$100.00
26
(4)

G-protein activator that can lead to activation of downstream kinases, potentially enhancing the activity of FLJ37512.

Okadaic Acid

78111-17-8sc-3513
sc-3513A
sc-3513B
25 µg
100 µg
1 mg
$291.00
$530.00
$1800.00
78
(4)

Inhibits protein phosphatases PP1 and PP2A, potentially increasing the phosphorylation and activity of FLJ37512.

Ouabain-d3 (Major)

sc-478417
1 mg
$516.00
(0)

Inhibits Na+/K+ ATPase, leading to altered ion gradients and activation of signaling pathways that could enhance FLJ37512 activity.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Broad-spectrum kinase inhibitor that could indirectly activate kinases involved in FLJ37512 signaling through negative feedback loops.

(−)-Epinephrine

51-43-4sc-205674
sc-205674A
sc-205674B
sc-205674C
sc-205674D
1 g
5 g
10 g
100 g
1 kg
$41.00
$104.00
$201.00
$1774.00
$16500.00
(1)

Activates adrenergic receptors, causing a cascade that could lead to activation of kinases that modulate FLJ37512 activity.

Bisindolylmaleimide I (GF 109203X)

133052-90-1sc-24003A
sc-24003
1 mg
5 mg
$105.00
$242.00
36
(1)

Selective PKC inhibitor that may result in the upregulation of FLJ37512 activity through compensatory cellular responses.